Monsheel Sodhi, PhD

Monsheel Sodhi, PhD

Molecular Pharmacology and Therapeutics

Assistant Professor

Languages Spoken

English

Clinical Expertise

  • Psychiatry Research

Medical Education

Medical School
Fellowship
  • University of Oxford, United Kingdom - Neuroscience
  • Vanderbilt University - Neuropharmacology

Board Certification

Research

  • Meta-analysis of sex differences in gene expression in schizophrenia Qin, W.; Liu, C.; Sodhi, M.; Lu, H., BMC SYSTEMS BIOLOGY
  • Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia Bristow, G. C.; Bostrom, J. A.; Haroutunian, V.; Sodhi, M. S., SCHIZOPHRENIA RESEARCH
  • Sex differences in glutamate receptor gene expression in major depression and suicide Gray, A. L.; Hyde, T. M.; Deep-Soboslay, A.; Kleinman, J. E.; Sodhi, M. S., MOLECULAR PSYCHIATRY
View All ResearchShow Less
  • The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia Bonaccorso, S.; Sodhi, M.; Li, J.; Bobo, W. V.; Chen, Y.; Tumuklu, M.; Theleritis, C.; Jayathilake, K.; Meltzer, H. Y., Bipolar disorders
  • Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty Hanson, R. L.; Gannon, M. J.; Khamo, N.; Sodhi, M.; Orr, A. M.; Stubbings, J., Journal of managed care pharmacy : JMCP
  • Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia Sodhi, M. S.; Simmons, M.; McCullumsmith, R.; Haroutunian, V.; Meador-Woodruff, J. H., Biological psychiatry
  • Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims Simmons, M.; Meador-Woodruff, J. H.; Sodhi, M. S., Neuroreport
  • Epigenetic mechanisms in schizophrenia Roth, T. L.; Lubin, F. D.; Sodhi, M.; Kleinman, J. E., Biochimica et biophysica acta
  • Role of glutamate in schizophrenia: integrating excitatory avenues of research Sodhi, M.; Wood, K. H.; Meador-Woodruff, J., Expert Review of Neurotherapeutics
  • 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J DBA/2J, and BALB/cJ mice, Hackler, E. A.; Airey, D. C.; Shannon, C. C.; Sodhi, M. S.; Sanders-Bush, E., Neuroscience research
  • A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts Sodhi, M. S.; Airey, D. C.; Lambert, W.; Burnet, P. W.; Harrison, P. J.; Sanders-Bush, E., Molecular pharmacology
  • A 5-HT2C receptor promoter polymorphism (HTR2C - 759C/T) is associated with obesity in women and with resistance to weight loss in heterozygotes, Pooley, E. C.; Fairburn, C. G.; Cooper, Z.; Sodhi, M. S.; Cowen, P. J.; Harrison, P. J., American journal of medical genetics.Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia bipolar disorder, and major depression, Tunbridge, E.; Burnet, P. W.; Sodhi, M. S.; Harrison, P. J., Synapse (New York, N.Y.)
  • Serotonin and brain development Sodhi, M. S.; Sanders-Bush, E., International review of neurobiology
  • RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia Sodhi, M. S.; Burnet, P. W.; Makoff, A. J.; Kerwin, R. W.; Harrison, P. J., MOLECULAR PSYCHIATRY
  • Pharmacogenetic prediction of clozapine response Arranz, M. J.; Munro, J.; Birkett, J.; Bolonna, A.; Mancama, D.; Sodhi, M.; Lesch, K. P.; Meyer, J. F.; Sham, P.; Collier, D. A.; Murray, R. M.; Kerwin, R. W., Lancet (London, England)
  • 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Arranz MJ, Erdmann J, Kirov G, Rietschel M, Sodhi MS, Albus M, Ball D, Maier W, Davies N, Franzek E, Abusaad, Weigelt B, Murray R, Shimron-Abarbanell D, Kerwin R, Propping P, Sham P, Nöthen MM, Collier DA., Neuroscience letters
  • Future therapies for schizophrenia. Sodhi MS, and Murray, R.M. , EXPERT OPINION ON THERAPEUTIC PATENTS
  • Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Arranz, M.J., Collier, D.A., Munro, J., Sham, P., Kirov, G., Sodhi MS, Roberts, G., Price, J., and Kerwin, R.W., Neuroscience letters
  • The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi MS, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G., Neuroreport
  • Association between clozapine response and allelic variation in the 5-HT2A receptor gene. Arranz MJ, Collier D, Sodhi MS, Ball DM, Roberts GW, Price J, Sham P, Kerwin R. , Lancet
  • Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Sodhi MS, Arranz MJ, Curtis DA, Sham PC, Ball DM, Roberts GW, Price J, Collier DA, Kerwin RW, Neuroreport